Related content

Combination Therapy with Arsenic Trioxide for Hematological Malignancies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 6, 2010-07 ,pp. : 504-510

Bentham Science Publishers

Access to resources Recommend Favorite

Outpatient parenteral antibiotic therapy in patients with haematological malignancies: A pilot study of an early discharge strategy

By Johansson Eva   Björkholm Magnus   Wredling Regina   Kalin Mats   Engervall Per  

Supportive Care in Cancer, Vol. 9, Iss. 8, 2001-11 ,pp. : 619-624

Springer Publishing Company

Access to resources Recommend Favorite

The Combination of Conventional Chemotherapy with New Targeted Therapy in Hematologic Malignancies: The Safety and Efficiency of Low- Dose Cytarabine Supports its Combination with New Therapeutic Agents in Early Clinical Trials

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 4, 2009-11 ,pp. : 243-255

Bentham Science Publishers

Access to resources Recommend Favorite

Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 4, 2009-11 ,pp. : 310-314

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial cell activation and proliferation in ovarian tumors: Two distinct steps as potential markers for antiangiogenic therapy response

By      

Molecular Medicine Reports, Vol. 5, Iss. 5, 2012-01 ,pp. : 1181-1184

Spandidos Publications

Access to resources Recommend Favorite